Mexico:
Cofepris Authorizes The First 38 Cannabis Products In México
27 November 2018
Basham, Ringe y Correa, S.C.
To print this article, all you need is to be registered or login on Mondaq.com.
COFEPRIS authorizes the first 38 cannabis products in
México
On November 21st, 2018, the Federal Commission for
the Protection Against Sanitary Risks announced that it has
authorized the first 38 cannabis products in México
following the guidelines published by said Commission on October
30, 2018.
These products include 21 food supplements, 9 cosmetic products,
6 food products and 2 prime materials in favor of seven different
companies established in México.
As these products are authorized in terms of the Guidelines,
they all contain less than 1% THC, but have other cannabinoids such
as CBD, in their composition.
The lawyers of the multidisciplinary cannabis practice group of
Basham, Ringe & Correa are at your service for any doubts or
commentaries related to this particular matter.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Mexico
Lower House Approves Healthcare System Reforms
WTW
A controversial healthcare reform proposal in Colombia that would shift control of healthcare system funding from private companies to the government is moving forward in the approval process.
New Definition Of Strategic Medicines
CorralRosales
The Regulation STFP-009-725-2023 of March 15, 2023 (the "Regulation"), issued by the Board for Fixing and Reviewing the Prices of Medicines for Human Use and Consumption (the "Board")...
Nueva definición de medicamentos estratégicos
CorralRosales
Mediante Resolución STFP-009-725-2023 de 15 de marzo de 2023 (la "Resolución"), el Consejo de Fijación y Revisión de Precios de Medicamentos de Uso y Consumo Humano (el "Consejo")...